While BRAF mutation is a frequent initiating event that activates the MAPK pathway, the inactivation of key tumor suppressor genes, such as CDKN2A, PTEN, and TP53, is crucial for overcoming BRAF-induced senescence and allowing the uncontrolled proliferation and survival that characterize melanoma. The gene discussed is CDKN2A; the disease is melanoma.